Boston Scientific (BSX) Net Income Growth (3y) (2012 - 2026)
Boston Scientific (BSX) Net Income Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | 280.49% |
| 10 | Steris | 21.44 Bn | 21.00 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.29% |
| Dec 31, 2025 | 68.12% |
| Sep 30, 2025 | 59.02% |
| Jun 30, 2025 | 45.14% |
| Mar 31, 2025 | 82.26% |
| Dec 31, 2024 | 82.15% |
| Sep 30, 2024 | 3.83% |
| Jun 30, 2024 | 20.07% |
| Mar 31, 2024 | 13.07% |
| Dec 31, 2023 | 33.67% |
| Sep 30, 2023 | 73.89% |
| Jun 30, 2023 | 56.38% |
| Mar 31, 2023 | 215.15% |
| Dec 31, 2022 | -67.20% |
| Sep 30, 2022 | 14.27% |
| Jun 30, 2022 | 19.07% |
| Mar 31, 2022 | -36.03% |
| Dec 31, 2021 | -37.77% |
| Sep 30, 2021 | -1.01% |
| Jun 30, 2021 | -30.58% |